Picture of Laboratorios Farmaceuticos Rovi SA logo

ROVI Laboratorios Farmaceuticos Rovi SA Cashflow Statement

0.000.00%
es flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Laboratorios Farmaceuticos Rovi SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line41.972.6183258220
Depreciation
Amortisation
Non-Cash Items-0.4471.77-1.60.1371.96
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-68.7-47.1-53-43.4-133
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-9.0446.9149238113
Capital Expenditures-40.5-39.7-40.9-51.4-55.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0530.0670.101-5.773.16
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-40.5-39.6-40.8-57.2-52
Financing Cash Flow Items-0.093-0.299-0.2881.082.39
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities21.4-21.5-62.7-155-161
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-28.1-14.345.925.9-99.6